Use Of Rank/Rankl Antagonists For Treating Neuromuscular Disorders, Genetic Myopathies And/Or Non Genetic Myopathies And/Or For Regulating Skeletal And Cardiac Muscle Disuse, Diseases And Aging

Patent No. EP2776066 (titled "Use Of Rank/Rankl Antagonists For Treating Neuromuscular Disorders, Genetic Myopathies And/Or Non Genetic Myopathies And/Or For Regulating Skeletal And Cardiac Muscle Disuse, Diseases And Aging") was filed by Universit Laval on Nov 6, 2012. The application was issued on Sep 19, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBBJun 18, 2019LAHRTZ

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2776066

UNIVERSIT LAVAL
Application Number
EP12847546A
Filing Date
Nov 6, 2012
Status
Revoked
Jan 15, 2021
Publication Date
Sep 19, 2018